The Stamp Out Breast Cancer Act (Public Law 105-41) authorized a special postage stamp for first-class mail. The price of this stamp is 60 cents, 11 cents above the current rate of 49 cents. The authority to issue the stamp expires on December 31, 2015. After accounting for the Postal Service’s administrative costs, amounts above the regular postal rate collected from sales of the special stamp are transferred to the National Institutes of Health (NIH) and the Department of Defense (DoD) to spend on breast cancer research. S. 1170 would extend this program until December 31, 2019.
CBO estimates that enacting S. 1170 would result in a net reduction in direct spending of $1 million over the 2016-2020 period, but those savings would be offset by increased direct spending in 2021 and 2022. Thus, under the bill there would be no net effect on direct spending over the 2016-2025 period. Pay-as-you-go procedures apply because enacting the legislation would affect direct spending. Enacting the legislation would not affect revenues.
S. 1170 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act and would not affect the budgets of state, local, or tribal governments.